Optometrists in Tinker Afb, OK Accepting Medicare
4 Optometrists found. Showing 1 - 4
 Tinker Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 3360 N Ave Bldg 685, Tinker Afb, OK 73145 Phone: 405-455-2587 Fax: 405-733-3124 |
 Dr. Emily M Thompson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7050 Air Depot Blvd Bldg 1094, Tinker Afb, OK 73145 Phone: 405-582-6516 |
 Dr. Anthony Trung Pham, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3360 N Ave Bldg 685, Tinker Afb, OK 73145 Phone: 405-455-2587 Fax: 405-733-3124 |
Amanda Catherine Quelly Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7050 Air Depot Blvd, Tinker Afb, OK 73145 Phone: 405-582-6516 |
News Archive
Article evaluates benefits and costs of screening programs for prevention of SCD
An article, published in Circulation by Laurel K. Leslie, MD, MPH from the Tufts Clinical and Translational Science Institute (CTSI) and colleagues from Tufts Medical Center and Floating Hospital for Children at Tufts Medical Center, has evaluated the lifesaving benefits and costs of screening programs for the prevention of sudden cardiac death (SCD) in children and adolescents.
Health disparities in heart attack hospital transfer patterns
Older, female and minority patients rushed to community hospitals with acute heart attacks are less likely to be transferred to a larger hospital that offers procedures to immediately open clogged arteries, Duke University Medical Center cardiologists have found.
HVTN opens enrollment in GeoVax's GM-CSF adjuvanted vaccine Phase 1 trial for HIV
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, today announced that the NIH-funded HIV Vaccine Trials Network (HVTN) has opened enrollment for a Phase 1 trial for the company's second-generation HIV vaccine.
Emergent commences Phase 2 combination trial of TRUw-016 with bendamustine in relapsed CLL
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 study (protocol 16201) of TRU-016 in combination with bendamustine for patients with relapsed chronic lymphocytic leukemia (CLL).
› Verified 4 days ago